Medical Therapy and Scleral Windows for Uveal Effusion Syndrome: A Case Series and Literature Review

• Published in: Ophthalmology and therapy Vol. 12; no. 1; pp. 35 - 53
• Main Authors: Li, Henry H., Hunter, Kaitlyn C., Thomson, Andrew C., Hunter, Allan A.
• Format: Journal Article
• Language: English
• Published: Cheshire Springer Healthcare 01-02-2023
• Subjects: Internal Medicine; Medicine; Medicine & Public Health; Ophthalmology; Review; Literature review; Choroidal effusion; Scleral windows; Uveal effusion syndrome
• ISSN: 2193-8245; 2193-6528
• DOI: 10.1007/s40123-022-00601-z

Introduction
Uveal effusion syndrome (UES) is a rare ocular disease causing idiopathic uveal effusion, often with associated ciliochoroidal and retinal detachment. UES diagnosis is challenging because of overlapping features with other ocular inflammatory, neoplastic, iatrogenic, and drug-induced causes of uveal effusion. While several successful surgical treatments have been described, such as full-thickness or partial-thickness sclerectomy, medical therapies may also have a therapeutic role.
Objective
To provide an updated review of the published literature on the course of the disease, medical and surgical management strategies, as well as newer treatment modalities.